Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Aurinia Pharmaceuticals Inc (AUPH) had Normalized Pre-Tax Income of $22.16M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$70.01M |
|
$21.51M |
|
$7.12M |
|
$62.89M |
|
$40.68M |
|
$29.33M |
|
$-7.17M |
|
$22.16M |
|
|
Normalized Pre-Tax Income |
$22.16M |
$21.51M |
|
$21.51M |
|
$21.51M |
|
$21.51M |
|
$29.33M |
|
$34.19M |
|
134.87M |
|
137.53M |
|
$0.16 |
|
$0.16 |
|
| Balance Sheet Financials | |
$408.97M |
|
$2.42M |
|
$93.59M |
|
$502.56M |
|
$78.27M |
|
$59.28M |
|
$89.00M |
|
$167.26M |
|
$335.30M |
|
$331.25M |
|
$335.30M |
|
132.67M |
|
| Cash Flow Statement Financials | |
$45.54M |
|
$17.76M |
|
$-93.73M |
|
$83.43M |
|
$53.00M |
|
$-30.43M |
|
$2.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.23 |
|
-- |
|
-- |
|
0.15 |
|
0.23 |
|
89.84% |
|
41.89% |
|
41.89% |
|
-- |
|
31.65% |
|
30.73% |
|
$45.43M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.15 |
|
1.75 |
|
51.54 |
|
6.42% |
|
6.49% |
|
4.28% |
|
5.45% |
|
$2.53 |
|
$0.33 |
|
$0.33 |
|